Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects

NCT04341077 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jiangsu HengRui Medicine Co., Ltd.